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Abstract
Foot ulcers are one of the problems that are often encountered in uncontrolled diabetes mellitus. With diabetic peripheral neuropathy, the typical clinical symptoms of PAD (peripheral
arterial disease) may be obscured, leading to critical limb ischemia (CLTI). Diabetes may accelerate atherosclerosis that diminishes blood flow in PAD—further, diabetic patients
with PAD often enfaces infra-popliteal lesions and require revascularization. However, studies on revascularization techniques in infra-popliteal PAD remain minimal. We reviewed
the literature on EBSCO, and PubMed focused on the revascularization techniques in PAD, namely: expanded polytetrafluoroethylene (ePTFE), saphenous vein graft (SVG),
atherectomy, surgical revascularization first, revascularization with endovascular bypass, direct and indirect angiosome revascularization, open surgery, direct bypass, indirect bypass,
PTA, drug-eluting stent, pedal artery angioplasty, non-drug balloon angioplasty, DCB balloon angioplasty, infra-popliteal angioplasty, and cryoplasty. The methods of cryoplasty,
atherectomy, direct bypass, balloon angioplasty, and eluting drug stent showed a better outcome in infra-popliteal CLTI.
Keywords: Revascularization, infra-popliteal peripheral arterial disease, diabetic foot, chronic limb-threatening ischemia

Introduction
Foot ulcers are the most common problems with diabetic foot. Further, it is
known that fifty percent of patients with diabetes and foot ulcers encounter
peripheral artery disease.1,2 Rathariwibowo (2014) shows that at dr. Cipto
Mangunkusumo general hospital (CMGH), there were 56.39% of
peripheral arterial disease (PAD) patients with critical limb-threatening
ischemia (CLTI), 61.3% with diabetes, and 33% underwent major
amputation.3 In Indonesia, the number of diabetic patients continues to
increase and is estimated to reach 21.3 million people by 2030 and is ranked
fourth with the highest number of diabetes worldwide.3.4
In a person with diabetes, peripheral neuropathy may obscure the typical
clinical symptoms of PAD, namely, claudication and pain at rest, leading
PAD to continue to CLTI, the most severe manifestation of PAD. In
addition, diabetes in PAD may accelerate atherosclerosis, worsening the
impaired blood flow. To this problem, treatment of revascularization and
non-revascularization is needed. Revascularization measures such as
endovascular and open surgery are required. However, the different
characteristics of PAD with diabetes than non-diabetes make
revascularization more challenging. This is because multisegmented and
bilateral lesions characterize PAD with diabetes with a more distal
predilection for lesions, especially in the infra–popliteal area/below the knee.
The arteries in infra–popliteal region have a smaller diameter than those in
the above-knee region. Thus, arterial calcification is more common,
particularly in the medial region. In addition, the poor quality of the collateral
arteries and the rapid progression of atherosclerosis leads diabetic patients to
be at high risk for CLTI and amputation.4
Studies on infra–popliteal PAD revascularization methods remain relatively
minimal, although diabetic patients with PAD often encounter lesions in the
infra-popliteal. In addition, the increasing number of diabetic patients
indicates that there will be an increase in diabetic ulcers with PAD requiring
revascularization.

The procedures of revascularization, particularly those of endovascular
performed in CMGH since 2012.3 Unfortunately, no study on the
revascularization of infra-popliteal PAD in the diabetic foot has been
conducted in the hospital. The authors proceeded with a literature search to
find high-quality evidence. The literature is required as the rational basis for
deciding on revascularization.
Method
The authors proceeded with literature searching on some online databases
(EBSCO and PubMed) provided by the library of Universitas Indonesia.
The author chooses these two online databases because other databases have
many duplications of the same journals. The keywords used were:
(peripheral arterial disease OR peripheral artery disease OR PAD) AND
(critical limb ischemia OR critical limb ischemia OR CLTI OR critical limbthreatening ischemia OR critical limb-threatening ischemia OR CLTI)
AND (diabetic foot OR diabetic foot OR diabetic ulcer * OR diabetic foot
ulcer OR diabetes *) AND (below the knee OR knee OR BTK OR infrapopliteal ) AND (angioplasty OR stent * OR drug-eluting OR drug coating
OR atherectomy OR balloon OR bypass OR open OR surgical OR surgery
OR endovascular OR EVR OR multi-vessel * OR pedal arch OR
angiosome * OR cryoplasty).
The inclusion criteria were those published within the last 20 years, studies
in patients with the diabetic foot with infra-popliteal PAD below the knee,
and revascularization measures such as open or endovascular surgery, one
of the outcomes was a reduction in restenosis, decreased amputation, and
mortality rates, healing of lesions, and the patency of revascularization, and,
definitely, available in full text. Furthermore, the articles were reviewed for
the quality of evidence and critically appraised. A specific critical appraisal
tool for cohort studies (prognostic studies) was used according to the Center
of Evidence-Based Medicine Critical Appraisal of Cohort Studies
University of Oxford, 2015.
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Results
Search using keywords on online databases, namely, EBSCO and PubMed,
according to the diagram based on PRISMA 2020 flow diagram. Ten
articles were included in this study, described in Tables 1, 2, and 3.

balloons (LDCB). They proceeded with follow-up for 390 days, and
Kaplan-Meier analysis showed 83.8% freedom of revascularization of the
target lesion at day 390. This retrospective study was categorized as a study
with level 2b in the hierarchy of evidence.
Troisi et al. investigated male-dominant patients with diabetic foot lesions
below the knee following direct-angiosome revascularization (DAR).
Follow-up was performed over one to 16 months. In addition, they
performed a Kaplan-Meier analysis for freedom from minor amputations,
limb salvage, and safety by comparing DAR with non-DAR examinations
and comparing the same based on the shape of the leg curve. This
retrospective cohort was categorized as a study with level 2b in the hierarchy
of evidence
Spillerova et al. investigated 545 diabetic patients with CLTI and defects to
evaluate the effect of angiosome–based revascularization. Patients were
monitored for one to twelve months postoperatively, and a Kaplan-Meier
analysis was performed to assess limb salvage and the progression of wound
healing. The study showed that 60.3% of ischemic wounds healed at a oneyear follow-up with a 95% confidence interval. At the number of affected
angiosome below 3, the wound healing rate was worst, while direct bypass
resulted in the best wound healing. While an amputation rate of 25.1% at
one-year follow-up of patients with atrial fibrillation, hemodialysis, Creactive protein level >10 mg/dL, and angiosome count affected >3 could be
significantly associated with poor limb salvage. This retrospective cohort
was categorized as a study with level 2b in the hierarchy of evidence

Figure 1. Literature searching following PRISMA protocol found ten eligible articles.

Of the eight cohort studies found, two studies (Neville et al. and Spillerova et
al.) met all the criteria (table 2). The study of Dayama et al. did not meet the
outcome criteria over time. They did not proceed with Kaplan-Meier
analysis, while the other five study groups did not meet the criteria for
accuracy in prognostic estimates because none discussed the number of
confidence intervals in the results. However, some studies produced
statistically significant results.
Neville et al. analyzed the outcomes of two groups of patients with similar
demographic characteristics. They proceeded with postoperative follow-up
and follow-up over 1 to 12 months to observe differences in outcomes of
tibial artery bypass with heparin-bonded expanded polytetrafluoroethylene
(HePTFE) and quality of the saphenous vein. The safety reported over time
using Kaplan-Meier charts showed that saphenous vein grafting (86%) had
a better outcome than the HePTFE (75%) and significant results with 95%
confidence intervals. The study is a retrospective cohort study using the
medical records of patients undergoing tibial artery bypass, referred to as a
study with level 2b in the hierarchy of evidence according to the Oxford
Center of Evidence-Based Medicine (OCEBM).
In the study of Das et al., patients with a diagnosis of CLTI from 16 sites were
pooled to investigate the use of cryoplasty in managing patients with a
below-knee occlusive disease and CLTI. The subjects were monitored
postoperatively at one, three, six, and twelve months. Kaplan-Meier analysis
showed an amputation-free rate of 89.3% on day 180. The study is a nonRCT but retrospective cohort; according to the OCEBM, it is categorized as
a study with level 2b in the hierarchy of evidence.
Palena et al. investigated 21 diabetic patients with CLTI and analyzed the
outcome of endovascular revascularization using Lutonix drug-coated

Dayama et al. investigated 1355 patients with CLTI below the genicular
artery. Two treatments, namely, endovascular-first and bypass-first
revascularization, were compared in the study. Monitoring was carried out
for 30 days, and the results were then adjusted according to the factors in each
subgroup and analyzed statistically with a 95% confidence interval. This
retrospective cohort study using data from "The American College of
Surgeons National Surgical Quality Improvement Program" was
categorized as a study with level 2b in the hierarchy of evidence.
Brizzi et al. included 282 CLTI patients undergoing endovascular treatment
to find out the survival rate, amputation–free, primary – and secondary
patency. The subjects were grouped into STENT, POBA, nitinol, BES, and
POBA sub-groups for comparison. Follow-up was performed at 0 to 35
months, and the Kaplan-Meier analysis showed 94% amputation-free,
64.9% survival, 74.9% primary patency, and 84.9% secondary patency.
This retrospective cohort study using data on European medical centers is
categorized as a study with level 2b in the hierarchy of evidence.
Commeau et al. investigated the efficacy and safety of sacrolimus-eluting
stents (SESs) as a treatment for CLTI with lesions below the knee unstable
for surgery were reviewed by improvement survival, amputation-free rate,
and patency. Follow-up was performed in 2-24 months and found clinical
improvement in 100% of patients. Kaplan-Meier analysis found 92.5%
survival and 82.5% amputation-free survival. This prospective cohort study
is categorized as a study with level 2b in the hierarchy of evidence.
The two remaining studies conducted by Teymen et al. (2017) 24and Rastan
et al. (2015)23 was categorized as a study with levels 1b and 2b in the
hierarchy of evidence, respectively.
In their study, Rastan et al. (2015),23 proceed with no blinding method to the
treatment group. However, the outcome is reliable with a 95% confidence
interval. They reported the loss to follow-up in 7 patients. While in the study
of Das et al. (2007),21 three patients were reported to a loss to follow-up.
Somehow, Teymen et al. (2017) 24and Rastan et al. (2015)23reported p-value
was not statistically significant.

28
33

The New Ropanasuri Journal of Surgery 2021 Volume 6 No.1:32–36

Table 1. List of articles obtained from literature searching
Sample
No
Author
Year
Size

Study Design

Intervention

Outcome

LOE

Drug-eluted balloon angioplasty, plain old
balloon angioplasty

Clinical improvement and wound healing

2b

1

Commeau et al.20

2006

30

Prospective cohort

2

Das et al.21

2007

108

Nonrandomized, controlled
trial

Technical success, mortality, amputation
rates
Number of amputations, patency, mortality,
morbidity

cryoplasty
Expanded fluoropolyethylene and vein
graft

3

Neville et al.22

2012

112

Retrospective cohort

4

Rastan et al.23

2015

189

Prospective cohort

5

Teymen et al.24

2017

48

Prospective cohort

6

Palena et al.25

2017

21

Retrospective cohort

7

Spillerova et al.27

2017

24

Retrospective cohort

Drug-coated balloon angioplasty and
POBA
Angiosome targeted PTA, endovascular
revascularization

8

Troisi et al.26

2017

93

Retrospective cohort

Complete pedal arch, incomplete pedal
arch

9

Brizzi et al.29

2018

282

Retrospective cohort

10

Dayama et al.28

2018

1354

Retrospective cohort

Directional atherectomy

2b
2b

Primary patency rate, procedural success,
freedom of amputation rate

2b

Freedom of amputation rate in one year,
MALE revascularization rate,

1b

survival rates, limb salvage

2b

primary patency rate assisted patency rate

2b

Freedom of amputation, limb salvage,
wound healing

2b

Drug-eluted balloon angioplasty, plain old
balloon angioplasty,

Primary and secondary patency, wound
healing, target lesion revascularisation

2b

Bypass first and endovascular first

MALE, MACE, amputation rate, patency,
mortality

2b

Open-cell stent; closed-cell stent

LOE: Level of evidence

Table 1. A critical review of cohort studies (prognostic studies) according to the Center of Evidence-Based Medicine Critical Appraisal of Cohort Studies University of Oxford 2015
Studies
Criteria
Neville et al.

Das et
al.

Palena et al.

Troisi et al.

Spillová
et al.

Dayama
et al.

Brizzi
et al.

Commeau et al.

A certain representative sample of patients is collected at the same point early in
the course of the disease

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

The follow-up is quite long and done

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Outcome criteria are objective or applied covertly

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

If there are subgroups with different prognoses, were adjustments made for
important prognostic factors?

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

No

Yes

Yes

Yes

No

Not

No

Yes

Yes

No

Not

Yes

Yes

Internal validity

Outcomes over time

+

Prognostic estimation accurac

*

Applicability
Can the important valid evidence from this study be applied to my patient
Yes
Yes
Yes
Yes
Yes
Yes
+
Outcomes over time are presented in each article in the form of a Kaplan-Meier curve (attached). *Prognostic estimation accuracy is expressed in confidence interval figure.

Table 2. Critical review for randomized control trial studies according to the Center of Evidence-Based Medicine Critical Appraisal of Cohort Studies University of Oxford
2015
Studies
Criteria
Teymen et al.24
Rastan et al.23
Were the patients in each treatment group randomized?
Yes
No
Were the groups consistent from the start of the experiment?
Yes
Yes
Is the treatment of each group the same?
Yes
Yes
Is there blinding from the beginning to the end of the study
Yes
No
Have any patients lost to follow- up?
Yes
Yes
Does the article report overall side effects?
Not
Yes
Are there significant differences in each group?
Exist
No
Are the results reliable?
Yes
Yes
Applicability
Is there a difference between my patient's condition and the study?
Yes
Yes
+
Outcomes over time are presented in each article in the form of a Kaplan-Meier curve (attached). *Prognostic estimation accuracy is expressed in confidence interval figure.
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Discussion
The basic revascularization techniques to treat infra-popliteal PAD in
diabetic foot patients are important to determine the best option for the
population. In this review, ten studies were included as references; they used
different techniques with different outcomes. For instance, Neville et al.
(2009)22 found that the expanded polytetrafluoroethylene (ePTFE) method
bound to heparin had no statistically significant difference compared with the
saphenous vein graft (SVG) in the distribution of the target tibial artery in the
anterior tibia (15 vs. 17 in ePTFE and SVG), posterior tibial (22 vs. 16),
dorsal pedis (4 vs. 5), and peroneal (21 vs. 12). Regarding survival, Neville
et al. (2009)22 found that the primary patency of the ePTFE method was
75%, and the primary patency of the SVG method was 86.4%. In addition,
end-stage renal disease contributed to decreased function and had an 86%
higher risk of death (95% CI, 64%-245%). On the other hand, when
compared with the two methods, SVG had a lower risk of occlusion or death
(95% CI, 14.2%-94.5%, p >0.05).
Rastan et al. (2015) 23 showed that the direct atherectomy resulted in a
primary patent of 84% for a year. The risk of amputation was reduced by
97.1%. Whereas Dayama et al. (2018)28, who compared endovascular–first
revascularization with the bypass–first revascularization, found that wound
complications in the bypass–first were 9.7%, while wound complications in
the endovascular–first were 3.7% and were statistically significant (p <0.01).
However, from the perspective of 30 days mortality, these two methods have
no significant difference. The mortality revascularization with the bypass–
first was 3.2%. and surgical revascularization–first was 1.8% (p = 0.1).
Some studies have also compared direct and indirect revascularization
methods. Spillerova et al. (2017)27 compared direct bypass, open surgical
methods, and PTA. This study found that in a 1-year follow-up, the cure rates
for the direct bypass method were 77%, 68.5% for the indirect bypass
method, 52.4% for the direct PTA method, and 52% for the direct the
indirect PTA method. For survival, it was found that the best wound healing
resulted from direct bypass (p = 0.003), while the one-year survival rates of
the three PTA, direct bypass, and indirect bypass methods were 25.5%,
21.4%, and 32.3%, respectively. Troisi et al. (2017)26 compared direct and
indirect revascularization methods. They found that direct and indirect
angiosome revascularization had no statistically significant difference in the
healing process after three months (direct = 23.6% vs. indirect = 23.7%, p =
1). From the perspective of free amputations (in one year), the direct
revascularization method showed a success of 74.4% and the indirect
revascularization method of 76.8%.
Commeau et al. (2006)20 reviewed the drug-eluting stent method. They
found that only two patients required amputation, one toe in one patient and
one in the other: 100% of the subject were free from the risk of amputation.
However, the mortality reported were two cardiac-related and one stroke
with hemiparesis, one early reperfusion syndrome, one contralateral CLTI,
and three cases of recurrent homolateral claudication. All survivors had
medium-term clinical improvement with 97% of primary patents (56 patent
arteries in 58 arteries).
The drug-eluted stent method was also compared with other methods.
Teymen et al. (2017),24 compared the drug-eluted stent method with the
same method with the addition of pedal artery angioplasty. In this study, the
mortality in the two methods was not statistically significant (in angioplasty
of 5% and without angioplasty of 8%, p = 1). The total amputated patients
were 15% in angioplasty and 24% without angioplasty (p = 0.291).
Meanwhile, another study by Brizzi et al. (2018)29compared the drug eluted
method and stent with non-medicated balloon angioplasty and showed that
complete wound healing was found in187 patients (82.7%), the overall limb
salvage rate was 94.0% with a survival rate of 89.2%. Primary and

secondary patency rates were 84.5% and 91.7%, respectively, with
significantly lower primary patency rates after stent placement (80.6% vs
87.6% after POBA; p = 0.043). The rate of freedom from target lesion
revascularization (TLR) was 86.3% with a significantly lower rate after stent
placement (81.8% vs 89.9% after POBA; p = 0.01). Subgroup analysis
showed no significant difference between nitinol stents, BESs, and POBA
in limb salvage and survival rates. However, primary and secondary patency
rates were significantly lower after BESs (primary and secondary patency
rates 84.0% after nitinol stents). vs. 77.4% after BESs vs. 87.6% after POBA;
p = 0.012 and 93.0% vs. 77.4% vs. 87.6%; p = 0.003, respectively), as well
as freedom from TLR levels (82.3% vs. 81.2% vs. 89.9%; p = 0.04). The
finding shows that the presence or absence of angioplasty has no significant
difference even though the morbidity and mortality rates are slightly lower
in the drug-eluted stent method with angioplasty.
Palena et al. (2017)25 compared angioplasty with a drug-coated balloon
(DCB angioplasty with the infra-popliteal method). They found that the
survival rate of DCB angioplasty was 90%, while that of infra-popliteal was
80% (p = 0.047). The survival rate from amputation in the DCB method was
100%, and infra-popliteal was 84% (p = 0.0003).
Das et al. (2007)21 reviewed one method only, namely the cryoplasty. A
balloon angioplasty inflated using NO fluid showed the advantage of
reducing vascular of being injured. They found that the success rate achieved
was 97.3%, the free of amputation rate was 93.4%, and there was a mortality
of 4.6%.
In summary, various revascularization techniques that are used to treat PAD
have been compared, namely: ePTFE, SVG, atherectomy, surgical
revascularization–first, endovascular bypass revascularization, direct and
indirect angiosome revascularization, open surgery, direct bypass, indirect
bypass, PTA, drug-eluting stent, pedal artery angioplasty, non-drug balloon
angioplasty, DCB balloon angioplasty, infra-popliteal angioplasty, and
cryoplasty. Several methods may be preferred depending on the patient's
condition and the risks involved because studies have shown a better
prognosis, including atherectomy, direct bypass, drug-eluting stent, balloon
angioplasty, and cryoplasty.
However, remember that this literature was conducted in developed
countries with different demographic conditions and more adequate health
facilities. Therefore, adjustments are required before applying in Indonesia,
which has other case characteristics. In addition, there are several studies with
small samples, namely the study conducted by Commeau et al. (2006),20 by
Teymen et al. (2017),24and Palena et al. (2017)25that may contribute to a bias
factor that affects the outcome.
Conclusions
Ten studies of high-quality evidence showed that endovascular surgery such
as cryoplasty, atherectomy, direct bypass, balloon angioplasty, and drugeluting stent is best to treat PAD with infra-popliteal CLTI with
revascularization.
Disclosure
The authors declare no conflict of interest
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